catechin and safingol

catechin has been researched along with safingol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimura, Y; Huang, Y; Kay, NE; Kim, YH; Kumazoe, M; Lesnick, C; Miura, D; Shanafelt, TD; Suzuki, T; Tachibana, H; Tsukamoto, S; Ueda, N; Yamada, S; Yamashita, S	1

Other Studies

1 other study(ies) available for catechin and safingol

Article	Year
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs. Molecular cancer therapeutics, 2015, Volume: 14, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Death-Associated Protein Kinases; Drug Synergism; Enzyme Activation; Female; Humans; Membrane Microdomains; Mice, Inbred BALB C; Multiple Myeloma; Phosphotransferases (Alcohol Group Acceptor); Receptor Protein-Tyrosine Kinases; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Xenograft Model Antitumor Assays	2015

Article

Year

Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Death-Associated Protein Kinases; Drug Synergism; Enzyme Activation; Female; Humans; Membrane Microdomains; Mice, Inbred BALB C; Multiple Myeloma; Phosphotransferases (Alcohol Group Acceptor); Receptor Protein-Tyrosine Kinases; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Xenograft Model Antitumor Assays

2015